Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,449,900 | 1,456,200 | 1,317,400 | 880,192 | 776,747 |
| Depreciation Amortization | 374,100 | 283,500 | 362,900 | 259,089 | 126,068 |
| Income taxes - deferred | -246,600 | 100,200 | -85,800 | -103,923 | -26,939 |
| Accounts receivable | -101,400 | -30,100 | -263,100 | -234,452 | -122,615 |
| Other Working Capital | 4,300 | -389,900 | 2,300 | -107,853 | -130,656 |
| Other Operating Activity | 745,600 | 598,700 | 442,400 | 488,503 | 287,250 |
| Operating Cash Flow | $2,225,900 | $2,018,600 | $1,776,100 | $1,181,556 | $909,855 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -119,700 | -111,500 | -38,900 | -98,632 | -93,384 |
| Net Acquisitions | N/A | -352,200 | N/A | -2,652,377 | N/A |
| Purchase Of Investment | -4,030,700 | -2,798,800 | -1,752,700 | -3,286,245 | -3,024,403 |
| Sale Of Investment | 3,642,300 | 1,743,700 | 2,175,200 | 3,931,883 | 2,258,376 |
| Purchase Sale Intangibles | N/A | -48,900 | 0 | N/A | N/A |
| Other Investing Activity | -20,500 | -34,800 | -5,900 | -1,934 | 3,333 |
| Investing Cash Flow | $-528,600 | $-1,553,600 | $377,700 | $-2,107,305 | $-856,078 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 4,462,000 | 4,494,800 | 1,878,800 | 0 | 0 |
| Debt Issued | 1,479,600 | 1,486,700 | 0 | 1,237,270 | 0 |
| Common Stock Issued | 552,800 | 476,200 | 166,500 | 86,889 | 49,751 |
| Common Stock Repurchased | -2,764,600 | -2,043,600 | -2,188,600 | -183,116 | -209,461 |
| Other Financing Activity | -4,283,500 | -4,662,900 | -1,478,700 | 36,124 | 97,838 |
| Financing Cash Flow | $-553,700 | $-248,800 | $-1,622,000 | $1,177,167 | $-61,872 |
| Exchange Rate Effect | 400 | 14,700 | -23,400 | -2,462 | 17,881 |
| Beginning Cash Position | 2,090,400 | 1,859,500 | 1,351,100 | 1,102,172 | 1,092,386 |
| End Cash Position | 3,234,400 | 2,090,400 | 1,859,500 | 1,351,128 | 1,102,172 |
| Net Cash Flow | $1,144,000 | $230,900 | $508,400 | $248,956 | $9,786 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,225,900 | 2,018,600 | 1,776,100 | 1,181,556 | 909,855 |
| Capital Expenditure | -119,700 | -111,500 | -132,100 | -98,632 | -93,384 |
| Free Cash Flow | 2,106,200 | 1,907,100 | 1,644,000 | 1,082,924 | 816,471 |